Loading company…
Vivendy Therapeutics develops enzyme replacement therapy for Morbus Morquio.
Vivendy Therapeutics is based in Basel, Switzerland, and develops an enzyme replacement therapy for Morbus Morquio, a rare lysosomal storage disease linked to a gene deficiency.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in